Analysis of USP Method <467> Residual Solvents on the Agilent 8890 GC System

Applications | 2019 | Agilent TechnologiesInstrumentation
GC, HeadSpace
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies

Significance of the Topic


Residual solvents from pharmaceutical production require strict monitoring to ensure patient safety and regulatory compliance. USP Method <467> outlines criteria for classifying and quantifying volatile impurities. A robust gas chromatography approach allows accurate identification and quantification of these solvents to maintain product quality.

Goals and Overview of the Study


This work demonstrates the performance of an Agilent 8890 GC system equipped with dual columns and flame ionization detectors for simultaneous application of USP <467> Procedures A and B. The study evaluates method compliance, repeatability, and chromatographic resolution for class 1, 2A, and 2B residual solvents.

Applied Methodology and Instrumentation


The system used an Agilent 7697A headspace sampler feeding an inert tee to split sample vapors between:
  • Column 1: J&W DB-Select 624 UI for 467 (30 m × 0.32 mm, 1.8 µm)
  • Column 2: J&W HP-INNOWax (30 m × 0.32 mm, 0.25 µm)

Both columns were connected to dual FIDs on an Agilent 8890 GC with split mode injection. Headspace conditions, carrier gas flow, temperature programs, and sample preparation followed USP <467> guidelines for class 1, 2A, and 2B solvents.

Main Results and Discussion


Chromatograms for all three solvent classes showed clear separation and met signal-to-noise and resolution requirements. Repeatability tests (n=10) yielded area and retention time RSDs below 5% across both columns, demonstrating excellent method stability. Coelutions noted in USP <467> were resolved by selecting the optimal column for quantification.

Benefits and Practical Applications


  • Simultaneous analysis of Procedures A and B reduces run time and sample consumption.
  • Dual-column, dual-FID configuration enhances confirmation of solvent identity and purity.
  • High repeatability and compliance with USP <467> support routine quality control in pharmaceutical laboratories.

Future Trends and Potential Applications


Advances may include faster headspace sampling techniques, improved column chemistries for greater solvent coverage, and integration with data analytics for automated compliance reporting. Emerging detectors and miniaturized GC systems could further streamline residual solvent monitoring.

Conclusion


The Agilent 8890 GC system with dual columns and FIDs paired with a headspace sampler offers a robust, compliant solution for USP Method <467> residual solvent analysis. Excellent chromatographic performance and repeatability make it suitable for high-throughput pharmaceutical QC environments.

References


  1. USP 32-NF 27, General Chapter USP <467> Organic volatile impurities, United States Pharmacopeia, Rockville, MD, USA.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Analysis of USP <467> Residual Solvents Using the Agilent 8697XL Headspace Sampler and Agilent 8890 GC
Residual solvents analysis using an Agilent Intuvo 9000 GC system
Residual Solvents Analysis Based on the 2025 USP <467> and Chinese Pharmacopoeia (ChP 0861)
Residual Solvents Analysis Using an Agilent Intuvo 9000 GC with 8697 Headspace Sampler